The pooled SMD of RMI2 was 1.29 (95% CI: 1.18–1.41, p = 0.000) (Figure 2A), which indicated that RMI2 expression was significantly upregulated in breast cancer tissues compared to normal tissues. This evidence concerns the gene RMI2 and breast cancer.